Mark L Baum - Net Worth and Insider Trading
Mark L Baum Net Worth
The estimated net worth of Mark L Baum is at least $99 Million dollars as of 2024-12-03. Mark L Baum is the CHIEF EXECUTIVE OFFICER of Harrow Inc and owns about 2,137,525 shares of Harrow Inc (HROW) stock worth over $89 Million. Mark L Baum is the Director of Eton Pharmaceuticals Inc and owns about 794,745 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $10 Million. Mark L Baum is also the Director of Ideal Power Inc and owns about 2,906 shares of Ideal Power Inc (IPWR) stock worth over $18,279. Details can be seen in Mark L Baum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark L Baum has not made any transactions after 2024-03-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark L Baum
Mark L Baum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark L Baum owns 6 companies in total, including Harrow Inc (HROW) , Eton Pharmaceuticals Inc (ETON) , and Ideal Power Inc (IPWR) among others .
Click here to see the complete history of Mark L Baum’s form 4 insider trades.
Insider Ownership Summary of Mark L Baum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HROW | Harrow Inc | 2024-03-22 | director & 10 percent owner & Chief Executive Officer |
| ETON | Eton Pharmaceuticals Inc | 2018-11-15 | director |
| IPWR | Ideal Power Inc | 2017-03-03 | director |
 | | 2007-05-28 | director & President |
| | 2006-10-03 | other: General Counsel |
| | 2003-12-20 | director & 10 percent owner & CEO |
Mark L Baum Latest Holdings Summary
Mark L Baum currently owns a total of 3 stocks. Among these stocks, Mark L Baum owns 2,137,525 shares of Harrow Inc (HROW) as of March 22, 2024, with a value of $89 Million and a weighting of 90.02%. Mark L Baum owns 794,745 shares of Eton Pharmaceuticals Inc (ETON) as of November 15, 2018, with a value of $10 Million and a weighting of 9.96%. Mark L Baum also owns 2,906 shares of Ideal Power Inc (IPWR) as of March 3, 2017, with a value of $18,279 and a weighting of 0.02%.
Latest Holdings of Mark L Baum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HROW | Harrow Inc | 2024-03-22 | 2,137,525 | 41.86 | 89,476,797 |
| ETON | Eton Pharmaceuticals Inc | 2018-11-15 | 794,745 | 12.46 | 9,902,523 |
| IPWR | Ideal Power Inc | 2017-03-03 | 2,906 | 6.29 | 18,279 |
Holding Weightings of Mark L Baum
Mark L Baum Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark L Baum has made a total of 4 transactions in Harrow Inc (HROW) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Harrow Inc is the acquisition of 9,000 shares on March 22, 2024, which cost Mark L Baum around $104,310.
According to the SEC Form 4 filings, Mark L Baum has made a total of 0 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 10,000 shares on November 15, 2018, which cost Mark L Baum around $60,000.
According to the SEC Form 4 filings, Mark L Baum has made a total of 0 transactions in Ideal Power Inc (IPWR) over the past 5 years. The most-recent trade in Ideal Power Inc is the acquisition of 780 shares on March 3, 2017, which cost Mark L Baum around $19,812.
Insider Trading History of Mark L Baum
- 1
Mark L Baum Trading Performance
GuruFocus tracks the stock performance after each of Mark L Baum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark L Baum is 17.94%. GuruFocus also compares Mark L Baum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark L Baum within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark L Baum's insider trading performs compared to the benchmark.
Performance of Mark L Baum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.44 | | | | | |
| Relative Return to S&P 500(%) | 8.59 | | | | | |
Mark L Baum Ownership Network
Mark L Baum Owned Company Details
What does Harrow Inc do?
Who are the key executives at Harrow Inc?
Mark L Baum is the director & 10 percent owner & Chief Executive Officer of Harrow Inc. Other key executives at Harrow Inc include 10 percent owner Opaleye Management Inc. , VP & Accounting and Reporting Andrew Boll , and director & 10 percent owner & Chairman of the Board Robert J Kammer .
Harrow Inc (HROW) Insider Trades Summary
Over the past 18 months, Mark L Baum made 3 insider transaction in Harrow Inc (HROW) with a net purchase of 22,300. Other recent insider transactions involving Harrow Inc (HROW) include a net purchase of 215,000 shares made by Opaleye Management Inc. , a net purchase of 20,000 shares made by Martin A. Makary ,
In summary, during the past 3 months, insiders sold 0 shares of Harrow Inc (HROW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harrow Inc (HROW) were sold and 257,300 shares were bought by its insiders, resulting in a net purchase of 257,300 shares.
Harrow Inc (HROW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harrow Inc Insider Transactions
Mark L Baum Mailing Address
Above is the net worth, insider trading, and ownership report for Mark L Baum. You might contact Mark L Baum via mailing address: C/o Imprimis Pharmaceuticals, Inc, 12264 El Camino Real, Suite 350, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
